With a backup to the backup, insulin makers say they’re primed for Brexit

[TomSea]

With a backup to the backup, insulin makers say they’re primed for Brexit
September 17, 2019

By Kate Holton and Paul Sandle

LONDON (Reuters) – For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking laws and warehouse capacity as they seek to guarantee the supply of life-saving drugs through a chaotic Brexit.

With Britain set to leave the European Union within weeks, Pinder Sahota at the world’s biggest insulin maker Novo Nordisk, and Sanofi’s Hugo Fry have rebuilt operations to withstand the most turbulent of events.

Read more at: https://www.oann.com/with-a-backup-to-the-backup-insulin-makers-say-theyre-primed-for-brexit/